Oncogenic EGFRvIII in glioblastoma cells induces FOSL1 [41], and it modulates the malignant features of glioma cells, so it was suggested as target for therapeutic interventions against malignant gliomas [42]. This evidence concerns the gene FOSL1 and glioblastoma.